We found an increase in Ki67 positive tumor antigen-specific CD8 T cells isolated from FOLFOX-treated tumors, indicating that CD8 T cells in FOLFOX-treated tumors are more proliferative in the tumor (Figure 5G). This evidence concerns the gene MKI67 and neoplasm.